Epidemiological analysis reveals rising type 2 diabetes burden in North Africa and the Middle East, highlighting the urgent need to address modifiable risk factors.
The burden of T2DM, in terms of mortality, DALYs, and YLDs, continues to rise in the region. The incidence rate of T2DM has increased in many areas. The burden of T2DM attributed to modifiable risk factors continues to grow in most countries. Targeting these modifiable risk factors could effectively reduce the growth and disease burden of T2DM in the region.
No takes yet. Share an insight, caveat, or question.
Namazi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: